Concepts (196)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Pre-Eclampsia | 6 | 2019 | 66 | 2.310 |
Why?
|
| Placenta | 4 | 2018 | 74 | 2.020 |
Why?
|
| Angiotensin I | 7 | 2016 | 241 | 1.650 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 3 | 2019 | 105 | 1.650 |
Why?
|
| Peptide Fragments | 7 | 2016 | 399 | 1.530 |
Why?
|
| Uterus | 4 | 2016 | 103 | 1.510 |
Why?
|
| Oxidative Stress | 5 | 2019 | 231 | 1.430 |
Why?
|
| Kidney | 9 | 2015 | 518 | 1.410 |
Why?
|
| Renin | 9 | 2015 | 109 | 1.310 |
Why?
|
| Pregnancy | 13 | 2019 | 997 | 1.130 |
Why?
|
| Rats | 19 | 2019 | 1595 | 1.120 |
Why?
|
| Peptidyl-Dipeptidase A | 6 | 2015 | 132 | 1.090 |
Why?
|
| Blood Pressure | 11 | 2016 | 845 | 1.030 |
Why?
|
| Hypertension | 6 | 2017 | 959 | 0.980 |
Why?
|
| Animals | 24 | 2019 | 7541 | 0.810 |
Why?
|
| Uterine Artery | 3 | 2015 | 5 | 0.760 |
Why?
|
| Pseudopregnancy | 3 | 2016 | 4 | 0.720 |
Why?
|
| Oxygen | 2 | 2017 | 142 | 0.680 |
Why?
|
| Microcirculation | 2 | 2016 | 65 | 0.670 |
Why?
|
| Rats, Sprague-Dawley | 8 | 2019 | 743 | 0.650 |
Why?
|
| Hemodynamics | 1 | 2019 | 155 | 0.630 |
Why?
|
| Sodium Chloride, Dietary | 4 | 2012 | 28 | 0.630 |
Why?
|
| Pregnancy Trimester, Third | 2 | 2015 | 18 | 0.600 |
Why?
|
| Endocannabinoids | 2 | 2015 | 35 | 0.600 |
Why?
|
| Down-Regulation | 2 | 2015 | 142 | 0.590 |
Why?
|
| Female | 24 | 2019 | 19959 | 0.590 |
Why?
|
| Ovariectomy | 4 | 2008 | 166 | 0.580 |
Why?
|
| Embryo Implantation | 2 | 2015 | 58 | 0.570 |
Why?
|
| 6-Ketoprostaglandin F1 alpha | 1 | 2016 | 3 | 0.570 |
Why?
|
| Dinoprostone | 1 | 2016 | 31 | 0.560 |
Why?
|
| Femoral Artery | 1 | 2016 | 50 | 0.550 |
Why?
|
| Angiotensin II | 7 | 2015 | 244 | 0.550 |
Why?
|
| Erythropoietin | 3 | 2015 | 30 | 0.540 |
Why?
|
| Amidohydrolases | 2 | 2015 | 8 | 0.530 |
Why?
|
| Disease Models, Animal | 7 | 2019 | 1022 | 0.520 |
Why?
|
| Chorionic Villi | 1 | 2015 | 7 | 0.520 |
Why?
|
| Umbilical Cord | 1 | 2015 | 8 | 0.510 |
Why?
|
| Ultrasonography | 1 | 2018 | 379 | 0.500 |
Why?
|
| Monoacylglycerol Lipases | 1 | 2015 | 5 | 0.500 |
Why?
|
| Receptors, Cannabinoid | 1 | 2015 | 25 | 0.500 |
Why?
|
| Nitric Oxide Synthase Type I | 2 | 2012 | 17 | 0.480 |
Why?
|
| MicroRNAs | 1 | 2017 | 180 | 0.480 |
Why?
|
| RNA, Messenger | 6 | 2015 | 508 | 0.480 |
Why?
|
| Rats, Inbred Lew | 8 | 2012 | 118 | 0.480 |
Why?
|
| Antihypertensive Agents | 1 | 2016 | 352 | 0.440 |
Why?
|
| Receptor, Angiotensin, Type 2 | 1 | 2013 | 22 | 0.440 |
Why?
|
| Receptors, Angiotensin | 1 | 2013 | 61 | 0.430 |
Why?
|
| Receptor, Angiotensin, Type 1 | 1 | 2013 | 65 | 0.430 |
Why?
|
| Ornithine | 1 | 2012 | 4 | 0.420 |
Why?
|
| Estrogens | 3 | 2008 | 180 | 0.410 |
Why?
|
| Muscle, Skeletal | 1 | 2016 | 519 | 0.410 |
Why?
|
| Reperfusion Injury | 1 | 2012 | 49 | 0.390 |
Why?
|
| Inflammation | 2 | 2012 | 530 | 0.390 |
Why?
|
| Diabetes Mellitus, Experimental | 1 | 2012 | 54 | 0.390 |
Why?
|
| Gene Expression Regulation, Enzymologic | 2 | 2015 | 80 | 0.390 |
Why?
|
| Mice, Inbred C57BL | 4 | 2018 | 767 | 0.370 |
Why?
|
| Fetal Growth Retardation | 3 | 2017 | 34 | 0.370 |
Why?
|
| Kidney Failure, Chronic | 2 | 2012 | 543 | 0.360 |
Why?
|
| Decidua | 3 | 2016 | 18 | 0.360 |
Why?
|
| Kidney Diseases | 3 | 2012 | 249 | 0.340 |
Why?
|
| Nitric Oxide Synthase | 1 | 2006 | 35 | 0.280 |
Why?
|
| Mice, Knockout | 3 | 2017 | 443 | 0.270 |
Why?
|
| Renin-Angiotensin System | 5 | 2012 | 179 | 0.260 |
Why?
|
| Regional Blood Flow | 2 | 2016 | 86 | 0.260 |
Why?
|
| Rats, Transgenic | 3 | 2019 | 47 | 0.230 |
Why?
|
| Mice | 5 | 2017 | 2484 | 0.230 |
Why?
|
| Pregnancy, Animal | 2 | 2014 | 19 | 0.220 |
Why?
|
| Angiotensinogen | 2 | 2019 | 59 | 0.200 |
Why?
|
| Blotting, Western | 2 | 2012 | 289 | 0.190 |
Why?
|
| Nitric Oxide Synthase Type III | 2 | 2012 | 36 | 0.170 |
Why?
|
| Nitrates | 2 | 2012 | 27 | 0.170 |
Why?
|
| Proteinuria | 2 | 2011 | 59 | 0.170 |
Why?
|
| Nitric Oxide | 2 | 2012 | 111 | 0.160 |
Why?
|
| C-Reactive Protein | 2 | 2012 | 238 | 0.160 |
Why?
|
| Humans | 8 | 2017 | 32005 | 0.160 |
Why?
|
| Glycerides | 2 | 2015 | 13 | 0.150 |
Why?
|
| Arachidonic Acids | 2 | 2015 | 23 | 0.150 |
Why?
|
| Immunohistochemistry | 2 | 2012 | 538 | 0.150 |
Why?
|
| NG-Nitroarginine Methyl Ester | 1 | 2017 | 18 | 0.150 |
Why?
|
| Young Adult | 2 | 2015 | 2636 | 0.150 |
Why?
|
| Hypoxia-Inducible Factor 1, alpha Subunit | 1 | 2017 | 23 | 0.150 |
Why?
|
| Fetus | 1 | 2018 | 86 | 0.150 |
Why?
|
| Imaging, Three-Dimensional | 1 | 2018 | 132 | 0.140 |
Why?
|
| Oximetry | 1 | 2016 | 31 | 0.140 |
Why?
|
| Pyrrolidonecarboxylic Acid | 1 | 2015 | 4 | 0.130 |
Why?
|
| Protein Precursors | 1 | 2015 | 22 | 0.130 |
Why?
|
| Protein Isoforms | 1 | 2015 | 57 | 0.130 |
Why?
|
| Tissue Culture Techniques | 1 | 2015 | 40 | 0.130 |
Why?
|
| Myocardial Ischemia | 1 | 2016 | 107 | 0.130 |
Why?
|
| Placental Circulation | 1 | 2015 | 1 | 0.130 |
Why?
|
| Rats, Nude | 2 | 2012 | 43 | 0.130 |
Why?
|
| Angiotensin II Type 1 Receptor Blockers | 1 | 2015 | 65 | 0.130 |
Why?
|
| Gene Expression Regulation, Developmental | 1 | 2015 | 69 | 0.130 |
Why?
|
| Protein Processing, Post-Translational | 1 | 2015 | 78 | 0.130 |
Why?
|
| Blood Flow Velocity | 1 | 2015 | 77 | 0.130 |
Why?
|
| Infusion Pumps | 1 | 2015 | 5 | 0.130 |
Why?
|
| Superoxides | 1 | 2015 | 19 | 0.120 |
Why?
|
| Male | 6 | 2016 | 19165 | 0.120 |
Why?
|
| Endopeptidases | 1 | 2015 | 26 | 0.120 |
Why?
|
| Collagen | 2 | 2015 | 225 | 0.120 |
Why?
|
| Hypertension, Pregnancy-Induced | 1 | 2014 | 13 | 0.120 |
Why?
|
| Vascular Resistance | 1 | 2014 | 31 | 0.120 |
Why?
|
| Up-Regulation | 1 | 2015 | 189 | 0.120 |
Why?
|
| Cardiac Output | 1 | 2014 | 36 | 0.120 |
Why?
|
| Vasoconstriction | 1 | 2014 | 43 | 0.120 |
Why?
|
| Forearm | 1 | 2014 | 43 | 0.120 |
Why?
|
| Myometrium | 1 | 2013 | 11 | 0.110 |
Why?
|
| Gestational Age | 1 | 2013 | 121 | 0.110 |
Why?
|
| Aldosterone | 3 | 2008 | 26 | 0.110 |
Why?
|
| Biopterin | 1 | 2012 | 3 | 0.100 |
Why?
|
| Nitrites | 1 | 2012 | 21 | 0.100 |
Why?
|
| Anemia | 1 | 2012 | 58 | 0.100 |
Why?
|
| Mutation | 1 | 2015 | 489 | 0.100 |
Why?
|
| Antigens, Differentiation, Myelomonocytic | 1 | 2012 | 21 | 0.100 |
Why?
|
| Neprilysin | 1 | 2012 | 31 | 0.100 |
Why?
|
| Fibrosis | 2 | 2015 | 120 | 0.100 |
Why?
|
| Blastocyst | 1 | 2011 | 11 | 0.100 |
Why?
|
| Chromatography, High Pressure Liquid | 1 | 2012 | 94 | 0.100 |
Why?
|
| Fetal Weight | 1 | 2011 | 6 | 0.100 |
Why?
|
| Gene Expression | 1 | 2013 | 338 | 0.100 |
Why?
|
| Cell Separation | 1 | 2012 | 92 | 0.100 |
Why?
|
| Case-Control Studies | 1 | 2014 | 898 | 0.100 |
Why?
|
| Muscle, Smooth, Vascular | 1 | 2012 | 63 | 0.100 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2012 | 263 | 0.100 |
Why?
|
| Gene Expression Regulation | 2 | 2012 | 495 | 0.100 |
Why?
|
| Antigens, CD | 1 | 2012 | 103 | 0.100 |
Why?
|
| Adult | 2 | 2015 | 9345 | 0.100 |
Why?
|
| Cell Transplantation | 1 | 2012 | 64 | 0.100 |
Why?
|
| Vascular Endothelial Growth Factor A | 1 | 2012 | 112 | 0.100 |
Why?
|
| Muscle Contraction | 1 | 2012 | 114 | 0.100 |
Why?
|
| Models, Animal | 2 | 2011 | 169 | 0.100 |
Why?
|
| Isoenzymes | 2 | 2011 | 61 | 0.090 |
Why?
|
| Receptors, G-Protein-Coupled | 1 | 2011 | 85 | 0.090 |
Why?
|
| Sex Characteristics | 1 | 2012 | 173 | 0.090 |
Why?
|
| Pregnancy Complications | 1 | 2011 | 105 | 0.090 |
Why?
|
| Heart Failure | 1 | 2016 | 639 | 0.090 |
Why?
|
| Cell Proliferation | 1 | 2012 | 604 | 0.080 |
Why?
|
| Sodium Chloride | 1 | 2008 | 22 | 0.080 |
Why?
|
| Animals, Congenic | 1 | 2007 | 14 | 0.070 |
Why?
|
| Diastole | 1 | 2008 | 96 | 0.070 |
Why?
|
| Hypertrophy | 1 | 2007 | 27 | 0.070 |
Why?
|
| Cell Adhesion Molecules | 1 | 2007 | 43 | 0.070 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 1 | 2007 | 73 | 0.070 |
Why?
|
| Insulin-Like Growth Factor I | 1 | 2007 | 84 | 0.070 |
Why?
|
| Nitric Oxide Synthase Type II | 1 | 2006 | 14 | 0.070 |
Why?
|
| Immunoblotting | 1 | 2006 | 51 | 0.070 |
Why?
|
| Kidney Cortex | 1 | 2006 | 25 | 0.070 |
Why?
|
| Kidney Medulla | 1 | 2006 | 29 | 0.070 |
Why?
|
| Ventricular Dysfunction, Left | 1 | 2008 | 170 | 0.070 |
Why?
|
| Enzyme Inhibitors | 1 | 2006 | 166 | 0.070 |
Why?
|
| Membrane Proteins | 1 | 2007 | 256 | 0.070 |
Why?
|
| Age Factors | 1 | 2008 | 1188 | 0.060 |
Why?
|
| Aging | 1 | 2007 | 946 | 0.050 |
Why?
|
| Renal Insufficiency, Chronic | 2 | 2015 | 291 | 0.040 |
Why?
|
| Middle Aged | 1 | 2012 | 11817 | 0.040 |
Why?
|
| Matrix Metalloproteinase 9 | 1 | 2015 | 30 | 0.030 |
Why?
|
| Superoxide Dismutase | 1 | 2015 | 45 | 0.030 |
Why?
|
| Monoglycerides | 1 | 2014 | 2 | 0.030 |
Why?
|
| Transforming Growth Factor beta | 1 | 2015 | 64 | 0.030 |
Why?
|
| Polyunsaturated Alkamides | 1 | 2014 | 9 | 0.030 |
Why?
|
| Benzodioxoles | 1 | 2014 | 6 | 0.030 |
Why?
|
| Hydrolysis | 1 | 2014 | 35 | 0.030 |
Why?
|
| Carbamates | 1 | 2014 | 15 | 0.030 |
Why?
|
| Creatinine | 1 | 2015 | 195 | 0.030 |
Why?
|
| Benzamides | 1 | 2014 | 50 | 0.030 |
Why?
|
| Phenotype | 1 | 2015 | 632 | 0.030 |
Why?
|
| Piperidines | 1 | 2014 | 118 | 0.030 |
Why?
|
| Apoptosis | 1 | 2015 | 360 | 0.030 |
Why?
|
| Cell Hypoxia | 1 | 2012 | 41 | 0.030 |
Why?
|
| Absorption | 1 | 2012 | 15 | 0.030 |
Why?
|
| Bioartificial Organs | 1 | 2012 | 25 | 0.030 |
Why?
|
| Kidney Tubules | 1 | 2012 | 26 | 0.030 |
Why?
|
| Albumins | 1 | 2012 | 45 | 0.030 |
Why?
|
| Cell Polarity | 1 | 2011 | 16 | 0.030 |
Why?
|
| Protein Transport | 1 | 2011 | 74 | 0.020 |
Why?
|
| Transplantation, Heterologous | 1 | 2012 | 122 | 0.020 |
Why?
|
| Mesenteric Arteries | 1 | 2011 | 20 | 0.020 |
Why?
|
| Cyclopentanes | 1 | 2011 | 16 | 0.020 |
Why?
|
| Fetal Development | 1 | 2011 | 26 | 0.020 |
Why?
|
| Quinolines | 1 | 2011 | 21 | 0.020 |
Why?
|
| Transfection | 1 | 2012 | 191 | 0.020 |
Why?
|
| Sodium, Dietary | 1 | 2011 | 23 | 0.020 |
Why?
|
| Kidney Tubules, Proximal | 1 | 2011 | 40 | 0.020 |
Why?
|
| Reference Values | 1 | 2011 | 246 | 0.020 |
Why?
|
| Cell Movement | 1 | 2012 | 169 | 0.020 |
Why?
|
| Random Allocation | 1 | 2011 | 226 | 0.020 |
Why?
|
| Vasodilation | 1 | 2011 | 94 | 0.020 |
Why?
|
| Cell Culture Techniques | 1 | 2012 | 173 | 0.020 |
Why?
|
| Estradiol | 1 | 2011 | 136 | 0.020 |
Why?
|
| Cells, Cultured | 1 | 2012 | 833 | 0.020 |
Why?
|
| Models, Biological | 1 | 2011 | 392 | 0.020 |
Why?
|
| Tissue Scaffolds | 1 | 2012 | 415 | 0.020 |
Why?
|
| Heart Failure, Diastolic | 1 | 2008 | 15 | 0.020 |
Why?
|
| Cardiomegaly | 1 | 2006 | 30 | 0.020 |
Why?
|
| Heart Rate | 1 | 2006 | 335 | 0.010 |
Why?
|
| Risk Factors | 1 | 2011 | 3876 | 0.010 |
Why?
|